AKT1 and breast cancer: Studies have shown that abnormal activation of the PI3K-AKT pathway plays a critical role in the occurrence, metastasis, and drug resistance of breast cancer, and it is closely related to the prognosis of breast cancer, all of which make it a potential therapeutic target for breast cancer [16,17].